Agranulocytosis related to clozapine in monozygotic twins and association with allelic variants of multidrug resistance gene MDR1

Journal of Clinical Psychopharmacology

Volumn 31, Issue 2, 2011, Pages 247-249

  Yaǧcoǧlu, A Elif Anl ^a   Ilhan, Bilge Çetin ^a   Göktaş, Mustafa T ^a   Babaoǧlu, Melih O ^a   Uz, Elif ^a   Yazc, M Kazm ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CLOZAPINE; GRANULOCYTE COLONY STIMULATING FACTOR; MULTIDRUG RESISTANCE PROTEIN 1; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGRANULOCYTOSIS; BODY TEMPERATURE; CASE REPORT; DNA EXTRACTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EXON; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LETTER; LEUKOCYTE COUNT; MALE; MDR1 GENE; MONOZYGOTIC TWINS; MULTIDRUG RESISTANCE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THERAPY RESISTANCE; TREATMENT DURATION; VENOUS BLOOD;

ADULT; AGRANULOCYTOSIS; ALLELES; CLOZAPINE; GENETIC VARIATION; HUMANS; MALE; P-GLYCOPROTEIN; SCHIZOPHRENIA, PARANOID; TWINS, MONOZYGOTIC;

EID: 79952419578     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31821084dc     Document Type: Letter

References (16)

1. Mosyagin I, Dettling M, Roots I, et al. Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis. J Clin Psychopharmacol. 2004;24:613-617. (Pubitemid 39518656)
2. Uetrecht JP. Metabolism of clozapine by neutrophils: possible implications for clozapine-induced agranulocytosis. Drug Saf. 1992;7 suppl 1:51-56.
3. Liu ZC, Uetrecht JP. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells. J Pharmacol Exp Ther. 1995;275:1476-1483. (Pubitemid 26130647)
4. Boulton DW, DeVane CL, Liston HL, et al. In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sci. 2002;71:163-169. (Pubitemid 34595435)
5. Wang JS, Zhu HJ, Markowitz JS, et al. Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology. 2006;187:415-423. (Pubitemid 44200513)
6. Fromm MF. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv Drug Deliv Rev. 2002;54:1295-1310. (Pubitemid 35284254)
7. Kerb R. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett. 2006;234:4-33. (Pubitemid 43343938)
8. Fromm MF. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci. 2004;25:423-429. (Pubitemid 38981558)
9. Tufan A, Babaoglu MO, Akdogan A, et al. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J Rheumatol. 2007;34:1540-1544. (Pubitemid 47067992)
10. Consoli G, Lastella M, Ciapparelli A, et al. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. Pharmacogenomics. 2009;10: 1267-1276.
11. Horacek J, Libiger J, Hoschl C, et al. Clozapine-induced concordant agranulocytosis in monozygotic twins. Int J Psychiatry Clin Pract. 2001;5:71-73. (Pubitemid 32410493)
12. Babaoglu MO, Bayar B, Aynacioglu AS, et al. Association of the ABCB1 3435C9T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists. Clin Pharmacol Ther. 2005;78:619-626. (Pubitemid 41773637)
13. Gerson SL, Meltzer H. Mechanisms of clozapine-induced agranulocytosis. Drug Saf. 1992;7 suppl 1:17-25.
14. Cascorbi I, Gerloff T, Johne A, et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther. 2001;69:169-174. (Pubitemid 32225417)
15. Fellay J, Marzolini C, Meaden ER, et al. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet. 2002;359:30-36. (Pubitemid 34119193)
16. Lidar M, Scherrmann JM, Shinar Y, et al. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum. 2004;33:273-282. (Pubitemid 38280826)